Wells Fargo Believes Abbott Labs (NYSE: ABT) Still Has Room to Grow

By Carrie Williams

Wells Fargo analyst Larry Biegelsen maintained a Buy rating on Abbott Labs (ABTResearch Report) today. The company’s shares opened today at $78.50, close to its 52-week high of $79.15.

According to TipRanks.com, Biegelsen is a 5-star analyst with an average return of 17.7% and a 73.1% success rate. Biegelsen covers the Healthcare sector, focusing on stocks such as Edwards Lifesciences, Wright Medical Group, and Johnson & Johnson.

Abbott Labs has an analyst consensus of Moderate Buy, with a price target consensus of $81, representing a 3.2% upside. In a report issued on March 8, Barclays also maintained a Buy rating on the stock with a $84 price target.

See today’s analyst top recommended stocks >>

The company has a one-year high of $79.15 and a one-year low of $56.81. Currently, Abbott Labs has an average volume of 6.58M.

Based on the recent corporate insider activity of 56 insiders, corporate insider sentiment is negative on the stock.

TipRanks has tracked 36,000 company insiders and found that a few of them are better than others when it comes to timing their transactions. See which 3 stocks are most likely to make moves following their insider activities.